Apixaban Market by Indication, Dosage Form & Distribution Channel

added blog Health

2025-08-07 10:38:49 -

According to FutureWise analysis the market for Apixaban in 2023 is US$ 1.87 billion, and is expected to reach US$ 2.96 billion by 2031 at a CAGR of 5.90%. Apixaban is a blood thinner that falls under the category of direct oral anticoagulants (DOACs). Apixaban is a blood thinner that falls under the category of direct oral anticoagulants (DOACs). It is commonly marketed under the brand name...

0 Comments 0 Shares 161 Views 0 Reviews